Drug class
Kinase Inhibitor
Mechanism of action
Kinase Inhibitors
General use cases
- Breast Neoplasms
- adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens in the metastatic setting [see Clinical Studies ( 14
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
